Literature DB >> 11752352

TTD: Therapeutic Target Database.

X Chen1, Z L Ji, Y Z Chen.   

Abstract

A number of proteins and nucleic acids have been explored as therapeutic targets. These targets are subjects of interest in different areas of biomedical and pharmaceutical research and in the development and evaluation of bioinformatics, molecular modeling, computer-aided drug design and analytical tools. A publicly accessible database that provides comprehensive information about these targets is therefore helpful to the relevant communities. The Therapeutic Target Database (TTD) is designed to provide information about the known therapeutic protein and nucleic acid targets described in the literature, the targeted disease conditions, the pathway information and the corresponding drugs/ligands directed at each of these targets. Cross-links to other databases are also introduced to facilitate the access of information about the sequence, 3D structure, function, nomenclature, drug/ligand binding properties, drug usage and effects, and related literature for each target. This database can be accessed at http://xin.cz3.nus.edu.sg/group/ttd/ttd.asp and it currently contains entries for 433 targets covering 125 disease conditions along with 809 drugs/ligands directed at each of these targets. Each entry can be retrieved through multiple methods including target name, disease name, drug/ligand name, drug/ligand function and drug therapeutic classification.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11752352      PMCID: PMC99057          DOI: 10.1093/nar/30.1.412

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  21 in total

1.  The ENZYME database in 2000.

Authors:  A Bairoch
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Tumor angiogenesis--new drugs on the block.

Authors:  V Brower
Journal:  Nat Biotechnol       Date:  1999-10       Impact factor: 54.908

3.  Drug discovery: a historical perspective.

Authors:  J Drews
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

Review 4.  New paths to pain relief.

Authors:  V Brower
Journal:  Nat Biotechnol       Date:  2000-04       Impact factor: 54.908

Review 5.  Drug discovery in the next millennium.

Authors:  E H Ohlstein; R R Ruffolo; J D Elliott
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

Review 6.  QSAR and CoMFA: a perspective on the practical application to drug discovery.

Authors:  B L Podlogar; D M Ferguson
Journal:  Drug Des Discov       Date:  2000

Review 7.  Advances in pharmacogenetics and pharmacogenomics.

Authors:  E S Vesell
Journal:  J Clin Pharmacol       Date:  2000-09       Impact factor: 3.126

Review 8.  Mitochondrial targets of drug toxicity.

Authors:  K B Wallace; A A Starkov
Journal:  Annu Rev Pharmacol Toxicol       Date:  2000       Impact factor: 13.820

9.  The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000.

Authors:  A Bairoch; R Apweiler
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

Review 10.  Mechanism-based target identification and drug discovery in cancer research.

Authors:  J B Gibbs
Journal:  Science       Date:  2000-03-17       Impact factor: 47.728

View more
  186 in total

1.  ONCOMINE: a cancer microarray database and integrated data-mining platform.

Authors:  Daniel R Rhodes; Jianjun Yu; K Shanker; Nandan Deshpande; Radhika Varambally; Debashis Ghosh; Terrence Barrette; Akhilesh Pandey; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2004 Jan-Feb       Impact factor: 5.715

2.  Genome sequencing and comparison of two nonhuman primate animal models, the cynomolgus and Chinese rhesus macaques.

Authors:  Guangmei Yan; Guojie Zhang; Xiaodong Fang; Yanfeng Zhang; Cai Li; Fei Ling; David N Cooper; Qiye Li; Yan Li; Alain J van Gool; Hongli Du; Jiesi Chen; Ronghua Chen; Pei Zhang; Zhiyong Huang; John R Thompson; Yuhuan Meng; Yinqi Bai; Jufang Wang; Min Zhuo; Tao Wang; Ying Huang; Liqiong Wei; Jianwen Li; Zhiwen Wang; Haofu Hu; Pengcheng Yang; Liang Le; Peter D Stenson; Bo Li; Xiaoming Liu; Edward V Ball; Na An; Quanfei Huang; Yong Zhang; Wei Fan; Xiuqing Zhang; Yingrui Li; Wen Wang; Michael G Katze; Bing Su; Rasmus Nielsen; Huanming Yang; Jun Wang; Xiaoning Wang; Jian Wang
Journal:  Nat Biotechnol       Date:  2011-10-16       Impact factor: 54.908

3.  A network-based method for target selection in metabolic networks.

Authors:  R Guimerà; M Sales-Pardo; L A N Amaral
Journal:  Bioinformatics       Date:  2007-04-26       Impact factor: 6.937

Review 4.  Normal mode analysis of biomolecular structures: functional mechanisms of membrane proteins.

Authors:  Ivet Bahar; Timothy R Lezon; Ahmet Bakan; Indira H Shrivastava
Journal:  Chem Rev       Date:  2010-03-10       Impact factor: 60.622

5.  Update of TTD: Therapeutic Target Database.

Authors:  Feng Zhu; BuCong Han; Pankaj Kumar; XiangHui Liu; XiaoHua Ma; Xiaona Wei; Lu Huang; YangFan Guo; LianYi Han; ChanJuan Zheng; YuZong Chen
Journal:  Nucleic Acids Res       Date:  2009-11-20       Impact factor: 16.971

Review 6.  Bioinformatics and systems biology of the lipidome.

Authors:  Shankar Subramaniam; Eoin Fahy; Shakti Gupta; Manish Sud; Robert W Byrnes; Dawn Cotter; Ashok Reddy Dinasarapu; Mano Ram Maurya
Journal:  Chem Rev       Date:  2011-09-23       Impact factor: 60.622

7.  The STAT3 inhibitor pimozide impedes cell proliferation and induces ROS generation in human osteosarcoma by suppressing catalase expression.

Authors:  Nan Cai; Wei Zhou; Lan-Lan Ye; Jun Chen; Qiu-Ni Liang; Gang Chang; Jia-Jie Chen
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

8.  Metolazone upregulates mitochondrial chaperones and extends lifespan in Caenorhabditis elegans.

Authors:  Ai Ito; Quichi Zhao; Yoichiro Tanaka; Masumi Yasui; Rina Katayama; Simo Sun; Yoshihiko Tanimoto; Yoshikazu Nishikawa; Eriko Kage-Nakadai
Journal:  Biogerontology       Date:  2020-11-20       Impact factor: 4.277

9.  Identifying unexpected therapeutic targets via chemical-protein interactome.

Authors:  Lun Yang; Jian Chen; Leming Shi; Michael P Hudock; Kejian Wang; Lin He
Journal:  PLoS One       Date:  2010-03-08       Impact factor: 3.240

10.  Perturbation of interaction networks for application to cancer therapy.

Authors:  Adrian P Quayle; Asim S Siddiqui; Steven J M Jones
Journal:  Cancer Inform       Date:  2007-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.